semaglutide 2024 Novo Nordisk withdraws FDA application to expand use of weight loss drug Company of the Year 2024:

This conclusion is supported by our IC and Ki data, where the dimer exhibits significantly lower values compared to the monomer

PlexusDx's Precision Peptide Genetic Test examines predispositions in key peptide genes (GLP1R, GIPR, FTO, MC4R) that may provide context during provider discussions about medication selection and expected response patterns

Chronic pain produces significant physiologic effects through neuroplastic changes in central nervous system pain pathways, dysregulates neurotransmitters such as substance P (an 11amino acid neuropeptide that functions as a neurotransmitter and modulator in both the central and peripheral nervous systems) and glutamate, and disrupts descending inhibitory pathways (3)(5)

33%, P = 0.007)

Movement of organic chemicals through landfill and hazardous waste disposal sites

Given the increasing real-world use of combined therapy and the limited HF-specific evidence base, this review summarizes current data regarding the comparative and combined effects of GLP-1 receptor agonists and SGLT2 inhibitors in HF, with emphasis on efficacy, safety, mechanistic rationale, and evidence gaps